Apr-15-21 Initiated
Atlantic Equities
Neutral
$122
Jan-28-21 Upgrade
BTIG Research
Neutral → Buy
$140
Sep-11-20 Initiated
Wolfe Research
Outperform
$124
Jun-01-20 Downgrade
Goldman
Neutral → Sell
$84
Mar-05-20 Initiated
Citigroup
Buy
$96
Feb-13-20 Initiated
Goldman
Neutral
$96
Feb-06-20 Resumed
BTIG Research
Neutral
Jan-02-20 Downgrade
Guggenheim
Buy → Neutral
Jun-13-19 Reiterated
BofA/Merrill
Buy
$81 → $90
Feb-07-19 Reiterated
BofA/Merrill
Buy
$73 → $81
Jan-02-19 Downgrade
Citigroup
Neutral → Sell
Nov-30-18 Upgrade
Goldman
Neutral → Buy
Oct-16-18 Initiated
Barclays
Overweight
$80
Jun-27-18 Initiated
Bernstein
Outperform
$73
Jan-30-18 Reiterated
Citigroup
Neutral
$59 → $64
Jan-25-18 Upgrade
William Blair
Mkt Perform → Outperform
Jan-25-18 Reiterated
Stifel
Buy
$63 → $71
Jan-03-18 Initiated
Evercore ISI
Outperform
Jan-02-18 Upgrade
Morgan Stanley
Equal-Weight → Overweight
Jan-02-18 Upgrade
JP Morgan
Neutral → Overweight
Apr-20-21 05:07PM
04:12PM Investor's Business Daily
02:30PM
11:22AM
10:04AM
09:49AM
08:55AM
08:02AM
07:57AM
07:44AM
07:41AM
07:30AM
05:07AM
Apr-19-21 06:00PM
09:49AM
08:30AM
Apr-15-21 06:59AM
Apr-14-21 01:47PM
Apr-13-21 05:50PM
12:30PM
08:55AM
Apr-12-21 09:19AM
08:00AM
Apr-10-21 09:00AM
Apr-09-21 04:06PM
Apr-08-21 01:38PM
09:00AM
07:18AM
Apr-07-21 09:28AM
Apr-06-21 09:00AM
Apr-05-21 01:32PM
09:47AM
09:22AM
Apr-01-21 09:42AM
08:55AM
07:32AM
Mar-31-21 11:18PM
11:06PM
Mar-30-21 06:40AM
Mar-29-21 11:30AM
10:30AM
Mar-28-21 06:15AM
Mar-26-21 12:17PM
09:24AM
08:16AM
06:08AM
04:00AM
Mar-25-21 09:10AM
09:06AM
08:47AM
07:43AM
Mar-24-21 11:06AM
09:31AM
08:19AM
Mar-23-21 02:38PM
01:27PM
08:56AM
Mar-22-21 04:05AM
Mar-21-21 10:01AM
Mar-19-21 07:19AM
06:00AM
Mar-18-21 03:07PM
01:15PM
10:40AM
Mar-17-21 05:50PM
01:56PM
09:36AM
Mar-16-21 01:42PM
12:20PM
07:00AM
Mar-15-21 12:48PM
12:46PM
Mar-12-21 11:30AM
Mar-11-21 05:45PM
09:00AM
Mar-09-21 11:27AM
09:16AM
Mar-08-21 09:22AM
09:00AM
05:51AM
04:04AM
Mar-06-21 01:15AM
Mar-05-21 05:45PM
11:09AM
09:27AM
09:04AM
09:00AM
08:56AM
Mar-04-21 09:39AM
09:17AM
08:38AM
Mar-03-21 12:42PM
09:35AM
09:00AM
Mar-02-21 04:35PM
08:05AM
07:45AM
04:41AM
Mar-01-21 12:45PM
11:15AM
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wainer Andrea F EXECUTIVE VICE PRESIDENT Mar 03 Sale 121.79 6,200 755,098 51,550 Mar 05 07:11 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT Mar 01 Sale 120.61 943 113,735 82,375 Mar 02 07:16 PM DALE MICHAEL D SENIOR VICE PRESIDENT Mar 01 Sale 120.61 1,475 177,900 39,691 Mar 02 07:13 PM BRYNELSEN CHARLES SENIOR VICE PRESIDENT Mar 01 Sale 120.61 1,002 120,851 43,550 Mar 02 07:02 PM BIRD ROGER SENIOR VICE PRESIDENT Mar 01 Sale 120.61 1,113 134,239 60,522 Mar 02 06:55 PM Ahlberg Gregory A SENIOR VICE PRESIDENT Mar 01 Sale 120.61 1,052 126,882 14,045 Mar 02 06:49 PM Ginascol John F EXECUTIVE VICE PRESIDENT Mar 01 Sale 120.61 352 42,455 99,321 Mar 02 07:30 PM WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDENT Mar 01 Sale 120.61 1,034 124,711 50,461 Mar 02 08:11 PM Watkin Jared SENIOR VICE PRESIDENT Mar 01 Sale 120.61 1,391 167,769 69,316 Mar 02 08:01 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Mar 01 Sale 120.61 587 70,798 57,750 Mar 02 07:59 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Mar 01 Sale 120.61 1,664 200,695 107,430 Mar 02 07:54 PM Kumbier Michelle Director Feb 23 Buy 122.50 2,040 249,900 7,296 Feb 25 06:05 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Feb 22 Sale 121.83 400 48,734 75,706 Feb 23 07:05 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Feb 16 Sale 128.49 505 64,887 63,373 Feb 18 05:57 PM Funck Robert E EXECUTIVE VICE PRESIDENT Feb 02 Option Exercise 39.12 31,325 1,225,434 193,542 Feb 04 06:56 PM MANNING JOSEPH J SENIOR VICE PRESIDENT Feb 02 Sale 123.03 3,130 385,084 59,681 Feb 03 07:20 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Feb 01 Option Exercise 38.78 203,393 7,887,902 355,289 Feb 03 07:10 PM Scoggins Christopher J SENIOR VICE PRESIDENT Feb 01 Option Exercise 44.83 45,000 2,017,200 84,706 Feb 03 07:14 PM MANNING JOSEPH J SENIOR VICE PRESIDENT Feb 01 Option Exercise 38.40 18,750 720,000 81,561 Feb 03 07:20 PM MANNING JOSEPH J SENIOR VICE PRESIDENT Feb 01 Sale 122.79 18,750 2,302,264 62,811 Feb 03 07:20 PM Scoggins Christopher J SENIOR VICE PRESIDENT Feb 01 Sale 123.24 45,000 5,545,800 39,706 Feb 03 07:14 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Feb 01 Sale 123.47 203,393 25,113,252 151,896 Feb 03 07:10 PM NOVAKOVIC PHEBE N Director Dec 04 Option Exercise 34.97 14,681 513,431 45,794 Dec 08 05:58 PM NOVAKOVIC PHEBE N Director Dec 04 Sale 107.28 4,790 513,849 41,004 Dec 08 05:58 PM OSBORN WILLIAM A Director Nov 24 Option Exercise 43.64 21,448 935,991 79,745 Nov 25 05:41 PM Funck Robert E Executive Vice President & CFO Oct 26 Option Exercise 38.40 83,333 3,199,987 265,550 Oct 28 06:33 PM Funck Robert E Executive Vice President & CFO Oct 26 Sale 108.83 83,333 9,068,955 182,217 Oct 28 06:33 PM Wainer Andrea F Executive Vice President Sep 30 Option Exercise 38.40 30,000 1,152,000 74,080 Oct 01 05:50 PM Wainer Andrea F Executive Vice President Sep 30 Sale 107.01 30,000 3,210,360 44,080 Oct 01 05:50 PM Wainer Andrea F Executive Vice President Sep 23 Sale 102.47 3,650 374,031 44,080 Sep 25 05:06 PM WOODGRIFT RANDEL WILLIAM Senior Vice President Sep 11 Sale 105.28 2,500 263,200 46,267 Sep 15 06:14 PM Ginascol John F Executive Vice President Sep 01 Option Exercise 43.16 72,098 3,111,584 136,775 Sep 03 06:33 PM BIRD ROGER Senior Vice President Sep 01 Sale 108.73 6,290 683,929 56,630 Sep 03 05:52 PM CAPEK JOHN M Executive Vice President Aug 27 Option Exercise 27.03 52,300 1,413,857 369,100 Aug 31 06:27 PM Salvadori Daniel Gesua Sive Executive Vice President Aug 27 Option Exercise 47.00 42,479 1,996,513 144,912 Aug 31 06:28 PM CAPEK JOHN M Executive Vice President Aug 27 Sale 111.86 52,300 5,850,278 316,800 Aug 31 06:27 PM Salvadori Daniel Gesua Sive Executive Vice President Aug 27 Sale 111.86 42,479 4,751,701 102,433 Aug 31 06:28 PM NOVAKOVIC PHEBE N Director Jul 23 Option Exercise 25.05 3,739 93,677 32,046 Jul 27 05:06 PM NOVAKOVIC PHEBE N Director Jul 23 Sale 100.78 933 94,026 31,113 Jul 27 05:06 PM AUSTIN ROXANNE S Director Jul 22 Sale 99.80 6,844 683,038 40,043 Jul 23 05:07 PM PEDERSON MICHAEL J Senior Vice President Jul 21 Option Exercise 0.00 23,008 0 96,899 Jul 23 05:04 PM PEDERSON MICHAEL J Senior Vice President Jul 21 Sale 98.00 23,008 2,254,784 73,891 Jul 23 05:04 PM Earnhardt Lisa D Executive Vice President Jun 10 Sale 90.84 872 79,216 72,074 Jun 12 05:07 PM LANE ANDREW H Executive Vice President May 05 Option Exercise 43.82 80,000 3,505,314 145,822 May 07 05:02 PM LANE ANDREW H Executive Vice President May 05 Sale 92.00 80,000 7,360,104 65,822 May 07 05:02 PM WOODGRIFT RANDEL WILLIAM Senior Vice President Apr 28 Sale 93.18 3,724 347,012 48,767 Apr 30 06:34 PM CAPEK JOHN M Executive Vice President Apr 21 Option Exercise 22.39 50,100 1,121,834 366,900 Apr 23 09:34 PM Ginascol John F Executive Vice President Apr 21 Option Exercise 38.40 63,200 2,426,880 129,645 Apr 23 09:41 PM Funck Robert E Executive Vice President & CFO Apr 21 Option Exercise 36.42 36,700 1,336,638 206,072 Apr 23 09:27 PM Contreras Jaime Senior Vice President Apr 21 Option Exercise 57.12 108,412 6,192,995 145,431 Apr 23 09:26 PM Scoggins Christopher J Senior Vice President Apr 21 Sale 96.10 414 39,785 39,706 Apr 23 09:28 PM Ginascol John F Executive Vice President Apr 21 Sale 96.00 63,200 6,067,051 66,445 Apr 23 09:41 PM CAPEK JOHN M Executive Vice President Apr 21 Sale 95.87 50,100 4,803,326 316,800 Apr 23 09:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite